A recent executive order issued by U.S. President Joe Biden heightened the level of scrutiny of inbound deals in certain sensitive industries. And now the U.S. is weighing legislation that calls for a "reverse CFIUS," which will add government scrutiny to outbound transactions.
Features & Analyses
- October 30, 2022
In the second part of this series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices look at the ever-expanding opportunities for cooperation between insurance companies and foreign investors amidst a complex regulatory landscape
October 28, 2022In the first part of a two-part series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices explain how foreign capital and Chinese insurance funds can aim to "dance with harmony" in China's private equity market, as they navigate multiple regulatory and practical challenges
October 21, 2022As the relationship between the U.S. and China has deteriorated, an increasing number of Chinese companies are ending their U.S.-based operations. Derek Liu, Rod Hunter and Howard Wu of Baker McKenzie set out some guidance for those heading down that path
October 14, 2022Casper Sek, Partner at Jingtian & Gongcheng, answers some frequently asked questions asked by foreign companies seeking to navigate China's cybersecurity and data laws
September 30, 2022The Supreme People's Court has made a ruling in what has become China's first patent linkage case. Fang Qi and Danlei Wu of Fangda Partners examine the potentially far-reaching implications of this significant decision
September 23, 2022Casper Sek, Partner at Jingtian & Gongcheng, examines newly-published guidelines which will bring welcome clarity and assistance to data handlers which are transferring data overseas
September 19, 2022Four Chinese companies have listed on the Swiss Exchange in recent months and a host of law firms have benefited. More such IPOs are in the pipeline, but will interest in European listings last?
September 14, 2022Jianwei (Jerry) Fang, Chao (David) Lv and Runyang Liu of Zhong Lun Law Firm highlight the newly revised regulatory measures for medical devices business enterprises and discuss heightened compliance requirements.
September 09, 2022Compliance Director at one of China's largest insurance companies speaks about current issues and future developments surrounding the country's insurance industry.
September 05, 2022










